- The Federal Trade Commission on Friday sued three large U.S. health companies that negotiate insulin prices, arguing the drug middlemen boost their profits while “artificially” inflating costs for patients.
- The suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group’s Optum Rx, CVS Health’s Caremark and Cigna’s Express Scripts, and their affiliated group purchasing organizations.
- The FTC may also recommend suing insulin manufacturers Eli Lilly, Sanofi and Novo Nordisk in the future.
Kahn is the real deal. I hope Harris keeps her and gives her anything she asks for.
Lina Kahn could be the trust buster we need to get America’s shit together and maybe reign in some of these big businesses that seem to be completely above the law.
Kahn is the real deal.
It’s Khan
Khaaaaaan!
Whatever her budget is, double it.
And send here a case of whatever she’s drinking
pharmabros be like
This is why I vote blue no matter who, right here.
Yes, Please. These fuckers are the devil. Sue them into oblivion. Rip the dollars out of their bloody hands.
I work for one of the parent companies of one of them and damn the propaganda has been crazy trying to discredit everything about the reports and the cases against them and trying to get employees to write to politicians and propagandize for them. They must be actually worried about the hit to profits over this. I mean it’s not like any tiny little fine will be a concern.
Independent pharmacist here
We’ve lost over 9 pharmacies a day in 2024 because of these guys who do everything they can to steer you to their mail order pharmacies.
They’re absolutely killing us and killing access. Please, do not use mail order.
Time to make a million lina khan clones and put them in government.
Noice
